The MOST Device has been listed with the FDA as a class 1 product available for sale.
Swallow Solutions, based in Madison, Wis., intends to launch a second generation of the MOST device.
More Articles on Gastroenterology:
Test to Detect Multiple Causes of Gastroenteritis Receives FDA Approval
Study Evaluates Efficacy of LINX Magnetic Device for Reflux Disease
Phenomenome Discoveries Develops Test to Identify Patients at Risk of Colon Cancer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
